Clinical Trial Update: A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating tibolone (Livial) on breast tissue in postmenopausal women with breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Livial (tibolone)

Snippet

Sponsor: Organon and Co | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED